Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank New treatment option for rare inflammatory disease 23 February 2018Press releaseHuman Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 February 2018 16 February 2018Press releaseVeterinary Veterinary medicines: highlights of 2017 13 February 2018NewsVeterinaryCorporate Regulatory information – adjusted fees for pharmacovigilance applications to EMA from 12 February 2018 12 February 2018NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 February 2018 9 February 2018NewsHumanPharmacovigilance PRAC recommends new measures to avoid valproate exposure in pregnancy 9 February 2018Press releaseHumanPharmacovigilance Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing 9 February 2018Press releaseHumanMedicinesPharmacovigilance Management Board started building approval process of EMA premises in Amsterdam 7 February 2018Press releaseCorporate General Court confirms EMA approach to transparency 6 February 2018Press releaseCorporate Strengthened guidance on follow-up and risk management for ATMP developers 1 February 2018NewsCorporateAdvanced therapies 1 … 122 123 124 125 126 Page 126 of 380 127 128 129 130 … 380
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 February 2018 16 February 2018Press releaseVeterinary
Regulatory information – adjusted fees for pharmacovigilance applications to EMA from 12 February 2018 12 February 2018NewsCorporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 February 2018 9 February 2018NewsHumanPharmacovigilance
PRAC recommends new measures to avoid valproate exposure in pregnancy 9 February 2018Press releaseHumanPharmacovigilance
Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing 9 February 2018Press releaseHumanMedicinesPharmacovigilance
Management Board started building approval process of EMA premises in Amsterdam 7 February 2018Press releaseCorporate
Strengthened guidance on follow-up and risk management for ATMP developers 1 February 2018NewsCorporateAdvanced therapies